OPEN Health Group Appoints New Leadership
November 18, 2020 |
OPEN Health Group today announced that Rob Barker has been appointed Chief Executive Officer. Rob succeeds outgoing CEO and Co-Founder, David Rowley, who is stepping down after 10 years. A portfolio company of Amulet Capital Partners, LP, OPEN Health is a leading multi-disciplinary health communications and market access group.
Mr. Barker has approximately 30 years of executive leadership experience in the biopharmaceuticals industry, including multiple roles at leading medical communications and strategy consulting firms. Most recently, he served as CEO of OPEN Health’s Medical Communications practice, having joined the business six years ago.
Mr. Barker expressed his enthusiasm for the continued growth and success of OPEN Health: “I am excited to be leading such a talented and expert team who have been instrumental in growing OPEN Health to its current position. We are now in a place to take even greater strides forward, and I feel confident that our continued focus on client service and scientific excellence will drive increased growth in the business.”
“Rob Barker has proven himself as an outstanding strategic and operational leader, and we are confident that he is the ideal executive to lead OPEN Health through its next exciting stage of growth,” said Ramsey Frank, Managing Partner and co-founder of Amulet. Amulet Partner Nick Amigone added, “Medical Affairs, Medical Communications, Market Access and HEOR have taken on increasingly important roles in bringing new therapies to market. Rob has been instrumental in assembling a suite of best-in-class capabilities at OPEN Health and driving the business to achieve its full potential.”
Mr. Frank added, “David Rowley leaves the business with our enormous thanks. He has grown OPEN Health from an initial idea to a leading global healthcare communications group. All his colleagues at OPEN Health are grateful to him and wish him well for the future. David will work with us in an advisory capacity to ensure a smooth transition.”
Mr. Rowley said “I have been CEO of OPEN Health since its inception, and I am incredibly proud of the company that we have built. This is the right time for me to be stepping down, and I wish Rob and the whole OPEN Health team continued success.”
About OPEN Health
OPEN Health is a multi-disciplinary health communications and market access group, operating across three core business areas: Medical Communications; Patient and Brand Communications; and Value, Informatics and Evidence. OPEN Health was formed in 2011, and whilst working across a broad therapeutic range has a strong focus on oncology, rare diseases and specialist medicines.
For more information on OPEN Health, please visit www.openhealthgroup.com.
About Amulet Capital Partners, LP
Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million.
For additional information, please visit www.amuletcapital.com.
Contacts for OPEN Health:
EU: Carwyn Jones
carwynjones@openhealthgroup.com
+44 20 3386 4728
USA: Candice Subero
csubero@openhealthgroup.com
+1 240-483-4323
Contact for Amulet Capital Partners:
Melissa Sheer
melissa@kentplacellc.com
+1 917-690-2199
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
Rare Disease Day 2021
To mark Rare Disease Day 2021 on Sunday 28 February, OPEN Health will be intentionally quiet on all LinkedIn channels from 26 February to 1 March in order not to…
What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
If the heart of the medical affairs industry is ultimately improving patient outcomes, internal training is the regenerative liver. Med affairs professionals need to regularly update their scientific knowledge and…
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
How fantastic is it to see that the National Organisation for Rare Disorders (NORD) has followed up on a survey undertaken in the late 80’s to pressure test progress and identify…
OPEN Health Group Appoints New Leadership
OPEN Health Group today announced that Rob Barker has been appointed Chief Executive Officer. Rob succeeds outgoing CEO and Co-Founder, David Rowley, who is stepping down after 10 years. A…
OPEN VIE and Pharmerit Bring the Best of Both Worlds to Virtual ISPOR Europe 2020
Join OPEN VIE and Pharmerit – an OPEN Health Company at the ISPOR European Virtual Conference from 16-19 November 2020 to see how we are shaping the healthcare industry with…
OPEN Health brings the Best of Both Worlds to MAPS EMEA 2020
Strategy and execution, data and insight, experience and innovation…what do you look for in an agency partner?OPEN Health is a family of expert practices working in partnership to drive positive…
OPEN Health delivers over 250 virtual activities during COVID-19 – A clear path forward
The COVID-19 pandemic has permanently changed how medical education in the healthcare industry is conducted. Over the last few months, all conferences, medical education and field force deliverables have either…
How Far Do You Want To Go?
Join OPEN Health’s virtual careers event on Tuesday 10th November, 15:00–17:00 GMT and discover where a career in medical communications could take you…
NORD Rare Diseases Breakthrough Summit
Gavin Jones, Director of Rare Disease, provides his thoughts on last week’s NORD Breakthrough Summit and a collective need to reduce inequalities in rare disease
The Patient as Priority: How can effective internal training contribute to improving patient outcomes?
Hear from OPEN Health’s Briony Frost